by Anastasia Budkina, CCO at medDARE
This week I had the pleasure of attending JFR 2025 in Paris — one of the most inspiring and insightful radiology gatherings in Europe. The discussions this year once again highlighted both the enormous potential and the ongoing challenges of medical AI adoption.
Here are a few of my key takeaways from the event:
Workforce shortage is becoming critical
There are simply not enough doctors ready to engage in clinical work — and even fewer who can contribute to data annotation or algorithm training. This gap is widening across Europe. At medDARE, we see this as precisely where we can help — by providing access to a trained annotation workforce, supported by our internal medical experts, to help bridge the gap between hospitals and AI developers.
Data privacy and GDPR compliance remain top priorities
For many clinics, ensuring GDPR compliance and properly anonymizing medical data are constant challenges. These are areas where medDARE’s expertise stands out — we’ve built our workflows around secure data handling, anonymization, and full regulatory compliance to make AI development both safer and faster.
The FDA still matters in Europe
Even though many companies focus on CE certification, FDA validation remains an important milestone for European AI developers. That’s why we continue to support our partners with data annotation and validation performed by certified U.S. radiologists — helping ensure models are ready for both markets.
Video data anonymization is still the hardest part
When it comes to endoscopic or surgical video data, anonymization is never simple. Even after automatic anonymization, a manual quality assurance step is always necessary — and while it’s complex and time-consuming, it’s also critical. We take pride in handling this process thoroughly at medDARE, ensuring both data integrity and compliance.
JFR 2025 reaffirmed how essential collaboration is between clinicians, data providers, and AI innovators. The challenges are real, but so are the opportunities — and I’m confident that with the right partnerships, we can make medical AI both safer and more scalable.
— Anastasia Budkina
Chief Commercial Officer, medDARE
